Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium.
Jacobs MT, Jain MD, Gao F, Nastoupil LJ, Spiegel JY, Lin Y, Dahiya S, Lunning M, Lekakis L, Reagan PM, Oluwole OO, McGuirk J, Deol A, Sehgal A, Goy A, Hill BT, Andreadis C, Munoz J, Chavez JC, Bennani NN, Rapoport AP, Vose JM, Miklos DB, Neelapu SS, Ghobadi A, Locke FL.
Jacobs MT, et al. Among authors: jain md.
Clin Lymphoma Myeloma Leuk. 2022 Oct;22(10):753-759. doi: 10.1016/j.clml.2022.05.004. Epub 2022 May 23.
Clin Lymphoma Myeloma Leuk. 2022.
PMID: 35780055